CVS Health Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
CVS Health (CVS) Tops Q2 EPS by 2c
August 8, 2017 6:58 AM EDTCVS Health (NYSE: CVS) reported Q2 EPS of $1.33, $0.02 better than the analyst estimate of $1.31. Revenue for the quarter came in at $45.7 billion versus the consensus estimate of $45.37 billion.
Comps decline 2.6%
GUIDANCE:
CVS Health sees FY2017 EPS of $5.83-$5.93,... More
